New Delhi: An expert panel of India’s central drug authority has recommended granting emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for children in the five to 11 years age group with certain conditions, official sources said Thursday. Biological E’s Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years. Covaxin has been granted Emergency Use Listing by the DCGI for the age group of 12 to 18 years on December 24, 2021. Biological E has also presented updated safety data for vaccination in the age group of 12 to 14 years from the immunisation programme. The next phase of vaccination commenced on January 3 for adolescents in the age group of 15-18 years.

Source: The Guardian April 21, 2022 17:35 UTC